Related Experiment Videos
Mucormycosis following bone marrow transplantation
Journal of the American Academy of Dermatology
|July 1, 1983
Summary
A rare case of disseminated mucormycosis caused by Rhizopus rhizopodiformis occurred in a bone marrow transplant patient. Despite prompt treatment, the aggressive fungal infection proved fatal.
Area of Science:
- Mycology
- Infectious Diseases
- Hematology
Background:
- Bone marrow transplantation (BMT) is a life-saving procedure but carries a significant risk of opportunistic infections.
- Mucormycosis is a rare, aggressive angioinvasive fungal infection, particularly concerning in immunocompromised hosts.
Observation:
- A 20-year-old female patient developed a disseminated mucormycosis with a primary cutaneous lesion post-BMT.
- The causative agent was identified as Rhizopus rhizopodiformis, a less common cause of mucormycosis.
Findings:
- Despite early clinical suspicion and initiation of amphotericin B therapy, the patient's condition rapidly deteriorated.
- The disseminated nature of the infection and the specific fungal species contributed to the poor outcome.
Implications:
- This case highlights the critical need for heightened vigilance for mucormycosis in BMT recipients, even with cutaneous presentations.
- Early and aggressive antifungal therapy is essential, but treatment challenges remain for disseminated infections caused by Rhizopus species.
- Further research into novel therapeutic strategies for mucormycosis in immunocompromised patients is warranted.